April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Does Greater Long-term Intraocular Pressure (IOP) Variability Increase Probability Of Developing Primary Open Angle Glaucoma (POAG) in the Ocular Hypertension Treatement Study (OHTS)?
Author Affiliations & Notes
  • Mae O. Gordon
    Ophthal & Vis Sciences,
    Division of Biostatistics,
    Washington Univ Sch of Med, St Louis, Missouri
  • Julia A. Beiser
    Ophthal & Vis Sciences,
    Washington Univ Sch of Med, St Louis, Missouri
  • J. Phillip Miller
    Division of Biostatistics,
    Washington Univ Sch of Med, St Louis, Missouri
  • Michael Kass
    Ophthal & Vis Sciences,
    Washington Univ Sch of Med, St Louis, Missouri
  • Feng Gao
    Division of Biostatistics,
    Washington Univ Sch of Med, St Louis, Missouri
  • Ocular Hypertension Treatment Study Group
    Washington Univ Sch of Med, St Louis, Missouri
  • Footnotes
    Commercial Relationships  Mae O. Gordon, None; Julia A. Beiser, None; J. Phillip Miller, None; Michael Kass, None; Feng Gao, None
  • Footnotes
    Support  NEI & Natl Ctr on Minority Health & Health Disparities, NIH(EY09341, EY09307, and Core Grant EY02687); Merck, White House Station; Pfizer & unrestricted grant from Research to Prevent Blindness
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 3442. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Mae O. Gordon, Julia A. Beiser, J. Phillip Miller, Michael Kass, Feng Gao, Ocular Hypertension Treatment Study Group; Does Greater Long-term Intraocular Pressure (IOP) Variability Increase Probability Of Developing Primary Open Angle Glaucoma (POAG) in the Ocular Hypertension Treatement Study (OHTS)?. Invest. Ophthalmol. Vis. Sci. 2011;52(14):3442.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To determine whether greater long-term IOP variability among observation participants increases the probability of developing POAG.

Methods: : Observation participants needed to have at least 3 study untreated IOPs to be included in this analysis. Univariate and multivariate Cox proportional hazards models were used to assess measures of IOP variability (standard deviation [SD], maximum [MAX], and range) on the probability of developing POAG. Data were censored after initiation of topical hypotensive medication. IOP variables were categorized into quartiles due to non-linearity. Multivariate (MV) models included baseline age, central corneal thickness (CCT), vertical cup to disc ratio (VCD), pattern standard deviation (PSD), mean follow-up (f/up) IOP (instead of baseline IOP) and a measure of IOP variability. C-statistic and calibration chi-square were used to asses predictive accuracy of models.

Results: : 696 of 819 participants randomized to observation had ≥ 3 untreated IOP measurements for inclusion in this analysis. The sample included 90 incident cases of POAG. Mean f/up IOP was 24.1 mmHg + 3.1 and mean duration of f/up was 6.4 years + 1.4. In univariate models, IOP SD (p=0.02) and MAX (p<0.0001) were statistically significant, range was not statistically significant (p=0.55). In MV models which included baseline age, CCT, VCD, PSD and mean f/up IOP, none of the measures of IOP variability was statistically significant (SD p=0.25, MAX p=0.98, range p=0.25). The c-statistic and calibration X2 for the MV prediction model without IOP variability were 0.82 and 6.41, respectively. The addition of IOP SD or MAX or range to this model did not improve the predictive accuracy (c-statistic of 0.82, 0.82 and 0.82, respectively and calibration X2 of 6.91, 6.14 and 2.24, respectively).

Conclusions: : Measures of IOP variability (SD, MAX, range) did not improve the predictive accuracy of the MV prediction model (baseline age, CCT, VCD, PSD and mean f/up IOP) in this sample.

Clinical Trial: : http://www.clinicaltrials.gov nct00000125

Keywords: clinical (human) or epidemiologic studies: risk factor assessment 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×